Vertex Pharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Vertex Pharmaceuticals, Inc. (VRTX)

441.36 +2.44 (+0.56%) USD | NASDAQ | Jan 16, 16:00

440.02 -1.34 (-0.30%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for VRTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Amgen, Inc.	--
Eli Lilly & Co.	Upgrade
Merck & Co., Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade